Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (311-320 of 372) with videos related to

Pageof 38
Sort By:
Hepatology (Baltimore, Md.)|December 24, 2005
Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis CCalogero Cammà, Savino Bruno, Vito Di Marco, et al.
Cells|April 12, 2022
Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of EndotoxemiaVincenzo La Mura, Nicoletta Gagliano, Francesca Arnaboldi, et al.
Hepatology (Baltimore, Md.)|September 12, 2015
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis BCarolina Boni, Pietro Lampertico, Lavinia Talamona, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective studySavino Bruno, Tommaso Stroffolini, Massimo Colombo, et al.
Annals of Internal Medicine|November 15, 2016
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized TrialMassimo Colombo, Alessio Aghemo, Hong Liu, et al.
Plos One|September 24, 2015
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or CirrhosisAntonia Lepida, Massimo Colombo, Inmaculada Fernandez, et al.
Hepatology Communications|September 14, 2021
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 UpdateLuca Valenti, Serena Pelusi, Cristiana Bianco, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Valentina Fabbris, et al.
Journal of Hepatology|February 24, 2009
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Jae Yeon Seok, et al.
Journal of Hepatology|February 15, 2011
Management of hepatitis C virus genotype 4: recommendations of an international expert panelMahmoud A Khattab, Peter Ferenci, Stephanos J Hadziyannis, et al.
Pageof 38

Showing results (311-320 of 372) with videos related to

Sort By:
Pageof 38
Hepatology (Baltimore, Md.)|December 24, 2005
Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis CCalogero Cammà, Savino Bruno, Vito Di Marco, et al.
Cells|April 12, 2022
Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of EndotoxemiaVincenzo La Mura, Nicoletta Gagliano, Francesca Arnaboldi, et al.
Hepatology (Baltimore, Md.)|September 12, 2015
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis BCarolina Boni, Pietro Lampertico, Lavinia Talamona, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective studySavino Bruno, Tommaso Stroffolini, Massimo Colombo, et al.
Annals of Internal Medicine|November 15, 2016
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized TrialMassimo Colombo, Alessio Aghemo, Hong Liu, et al.
Plos One|September 24, 2015
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or CirrhosisAntonia Lepida, Massimo Colombo, Inmaculada Fernandez, et al.
Hepatology Communications|September 14, 2021
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 UpdateLuca Valenti, Serena Pelusi, Cristiana Bianco, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Valentina Fabbris, et al.
Journal of Hepatology|February 24, 2009
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Jae Yeon Seok, et al.
Journal of Hepatology|February 15, 2011
Management of hepatitis C virus genotype 4: recommendations of an international expert panelMahmoud A Khattab, Peter Ferenci, Stephanos J Hadziyannis, et al.
Pageof 38